Protein Microarray Analysis in Patients with Asthma: Elevation of the Chemokine PARC/CCL18 in Sputum

Overview

Journal Chest

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2008 Nov 20

PMID 19017877

Citations 15

Authors

Hyo-Bin Kim

Chang-Keun Kim

Koji Iijima

Takao Kobayashi

Hirohito Kita

Affiliations

Soon will be listed here.

Abstract

Background: Microarray technology offers a new opportunity to gain insight into global gene and protein expression profiles in asthma. To identify novel factors produced in the asthmatic airway, we analyzed sputum samples by using a membrane-based human cytokine microarray technology in patients with bronchial asthma (BA).

Methods: Induced sputum was obtained from 28 BA subjects, 20 nonasthmatic atopic control (AC) subjects, and 38 nonasthmatic nonatopic normal control (NC) subjects. The microarray samples of subjects were randomly selected from nine BA subjects, three AC subjects, and six NC subjects. Sputum supernatants were analyzed using a custom human cytokine array (RayBio Custom Human Cytokine Array; RayBiotech; Norcross, GA) designed to analyze 79 specific cytokines simultaneously. The levels of growth-regulated oncogene (GRO)-alpha, eotaxin-2, and pulmonary and activation-regulated chemokine (PARC)/CCL18 were measured by sandwich enzyme-linked immunosorbent assays (ELISAs), and eosinophil-derived neurotoxin (EDN) was measured by radioimmunoassay.

Results: By microarray, the signal intensities for GRO-alpha, eotaxin-2, and PARC were significantly higher in BA subjects than in AC and NC subjects (p = 0.036, p = 0.042, and p = 0.033, respectively). By ELISA, the sputum PARC protein levels were significantly higher in BA subjects than in AC and NC subjects (p < 0.0001). Furthermore, PARC levels correlated significantly with sputum eosinophil percentages (r = 0.570, p < 0.0001) and the levels of EDN (r = 0.633, p < 0.0001), the regulated upon activation, normal T cell expressed and secreted cytokine (r = 0.440, p < 0.001), interleukin-4 (r = 0.415, p < 0.01), and interferon-gamma (r = 0.491, p < 0.001).

Conclusions: By a nonbiased screening approach, a chemokine, PARC, is elevated in sputum specimens from patients with asthma. PARC may play important roles in development of airway eosinophilic inflammation in asthma.

Citing Articles

Creatine Kinase Is Decreased in Childhood Asthma.

Guerra S, Ledford J, Melen E, Lavi I, Carsin A, Stern D Am J Respir Crit Care Med. 2022; 207(5):544-552.

PMID: 35876143 PMC: 10870915. DOI: 10.1164/rccm.202010-3746OC.

Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review).

Berghi N, Dumitru M, Vrinceanu D, Ciuluvica R, Simioniuc-Petrescu A, Caragheorgheopol R Exp Ther Med. 2020; 20(3):2352-2360.

PMID: 32765714 PMC: 7401840. DOI: 10.3892/etm.2020.8961.

Characterisation of asthma subgroups associated with circulating YKL-40 levels.

Gomez J, Yan X, Holm C, Grant N, Liu Q, Cohn L Eur Respir J. 2017; 50(4).

PMID: 29025889 PMC: 5967238. DOI: 10.1183/13993003.00800-2017.

Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Larose M, Archambault A, Provost V, Laviolette M, Flamand N Front Med (Lausanne). 2017; 4:136.

PMID: 28848734 PMC: 5554517. DOI: 10.3389/fmed.2017.00136.

CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study.

Takaku Y, Soma T, Uchida Y, Kobayashi T, Nakagome K, Nagata M Asthma Res Pract. 2016; 2:6.

PMID: 27965774 PMC: 5142415. DOI: 10.1186/s40733-016-0021-y.

References

DAmbrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A . Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol. 1998; 161(10):5111-5. View

Kodadek T . Protein microarrays: prospects and problems. Chem Biol. 2001; 8(2):105-15. DOI: 10.1016/s1074-5521(00)90067-x. View

Fahy J, Liu J, Wong H, Boushey H . Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis. 1993; 147(5):1126-31. DOI: 10.1164/ajrccm/147.5.1126. View

Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J . Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993; 150(3):1000-10. View

Pivarcsi A, Gombert M, Dieu-Nosjean M, Lauerma A, Kubitza R, Meller S . CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol. 2004; 173(9):5810-7. DOI: 10.4049/jimmunol.173.9.5810. View

Forssmann U, Uguccioni M, Loetscher P, Dahinden C, Langen H, Thelen M . Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med. 1997; 185(12):2171-6. PMC: 2196360. DOI: 10.1084/jem.185.12.2171. View

Li X, Chopra R, Chou T, Schofield B, Wills-Karp M, Huang S . Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol. 1996; 157(8):3216-9. View

Rankin S, Conroy D, Williams T . Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today. 2000; 6(1):20-7. DOI: 10.1016/s1357-4310(99)01635-4. View

Goebeler M, Trautmann A, Voss A, Brocker E, Toksoy A, Gillitzer R . Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol. 2001; 158(2):431-40. PMC: 1850305. DOI: 10.1016/s0002-9440(10)63986-7. View

10.

Nakajima H, Takatsu K . Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol. 2006; 142(4):265-73. DOI: 10.1159/000097357. View

11.

Reape T, Rayner K, Manning C, Gee A, Barnette M, Burnand K . Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol. 1999; 154(2):365-74. PMC: 1850009. DOI: 10.1016/S0002-9440(10)65283-2. View

12.

Sallusto F, Mackay C, Lanzavecchia A . Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997; 277(5334):2005-7. DOI: 10.1126/science.277.5334.2005. View

13.

Schraufstatter I, Takamori H, Sikora L, Sriramarao P, Discipio R . Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages. Am J Physiol Lung Cell Mol Physiol. 2003; 286(3):L494-501. DOI: 10.1152/ajplung.00323.2002. View

14.

Cho S, Stanciu L, Holgate S, Johnston S . Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med. 2004; 171(3):224-30. DOI: 10.1164/rccm.200310-1416OC. View

15.

MacBeath G . Protein microarrays and proteomics. Nat Genet. 2002; 32 Suppl:526-32. DOI: 10.1038/ng1037. View

16.

Prause O, Laan M, Lotvall J, Linden A . Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol. 2003; 462(1-3):193-8. DOI: 10.1016/s0014-2999(03)01341-4. View

17.

Hansen G, Berry G, DeKruyff R, Umetsu D . Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 1999; 103(2):175-83. PMC: 407883. DOI: 10.1172/JCI5155. View

18.

Carlson M, Hakansson L, Peterson C, Stalenheim G, Venge P . Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol. 1991; 87(1 Pt 1):27-33. DOI: 10.1016/0091-6749(91)90209-7. View

19.

Nomura I, Gao B, Boguniewicz M, Darst M, Travers J, Leung D . Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003; 112(6):1195-202. DOI: 10.1016/j.jaci.2003.08.049. View

20.

Wuyts A, Van Osselaer N, Haelens A, Samson I, Herdewijn P, Ben-Baruch A . Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry. 1997; 36(9):2716-23. DOI: 10.1021/bi961999z. View